Matinas BioPharma Holdings (MTNB) Invested Capital (2015 - 2026)
Matinas BioPharma Holdings (MTNB) posted quarterly Invested Capital of $7000.0 for Q1 2026, down 58.82% year-over-year from $17000.0 in Q1 2025, and little changed quarter-over-quarter from $7000.0 in Q4 2025.
Matinas BioPharma Holdings (MTNB) Invested Capital (2015 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Invested Capital for 9 consecutive years, with $7000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital fell 58.82% year-over-year to $7000.0; the TTM figure through Mar 2026 stood at $46000.0 (down 36.99% YoY), while the FY2025 annual figure was $7000.0, down 58.82% from the prior year.
- Invested Capital was little changed at $7000.0 in Q1 2026 per MTNB's latest filing, from $7000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $29000.0 in Q4 2022 and bottomed at $7000.0 in Q4 2025.
- Historically, Invested Capital has averaged $17823.5 across 5 years, with a median of $17000.0 in 2022.
- Annual changes were most pronounced in 2022 — Invested Capital slumped 73.33% — and 2023, when it jumped 200.0%.
- Matinas BioPharma Holdings' Invested Capital stood at $29000.0 in 2022, then declined by 20.69% to $23000.0 in 2023, then dropped by 26.09% to $17000.0 in 2024, then tumbled by 58.82% to $7000.0 in 2025, then changed by 0.0% to $7000.0 in 2026.
- Business Quant data shows MTNB's Invested Capital at $7000.0 in Q1 2026, $7000.0 in Q4 2025, and $16000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 30,000.00 |